Highmark Health revenue, net income up despite industry headwinds https://lnkd.in/gdRfKVee The Pittsburgh-based nonprofit has operations in Pennsylvania, New York, West Virginia, and Delaware, among elsewhere. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Pennsylvania NY NJ Biotech Networks
生物技术
Life science news & jobs from Pennsylvania, New York & New Jersey, including Philadelphia & NYC. A Biotech Networks hub.
关于我们
Life science news, jobs and events from Pennsylvania, New York and New Jersey, including Philadelphia & NYC. Part of Biotech Networks, connecting #biotech since 2008.
- 网站
-
https://pnbn.org
Pennsylvania NY NJ Biotech Networks的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 创立
- 2022
动态
-
Roche’s TIGIT prospect fails another phase 3 lung cancer test https://lnkd.in/gtzxqsRT Roche’s Skyscraper-01 has fallen down. The phase 3 trial?found adding the TIGIT candidate tiragolumab to Roche’s approved checkpoint inhibitor had no effect on overall survival (OS) in non-small cell lung cancer (NSCLC). Investigators enrolled 534 [...]
Roche’s TIGIT prospect fails another phase 3 lung cancer test
https://pnbn.org
-
Highmark reports net loss here as parent company fares better https://lnkd.in/g_GNh959 Highmark Western and Northeastern New York cited the Medicare Advantage segment, where policy changes and increased services have led to significant losses. Click here to view original post Click Here to Publish/Feature Your Company or [...]
Highmark reports net loss here as parent company fares better
https://pnbn.org
-
New data could help Merck expand use of cardiovascular drug https://lnkd.in/g2guFreH Adding Merck & Co.’s new cardiovascular drug Winrevair to background therapy helped people with severe lung hypertension stay alive and avoid invasive medical care longer than those who only received background therapy, the company said [...]
New data could help Merck expand use of cardiovascular drug
https://pnbn.org
-
Ellis Medicine moving finance employees to downtown Schenectady https://lnkd.in/gRdvcHWb The Ellis Medicine staff have been working at a Schenectady site that’s in line to be redeveloped. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Ellis Medicine moving finance employees to downtown Schenectady
https://pnbn.org
-
Welltower acquires two Philadelphia-area senior living communities for $42.7M https://lnkd.in/gE8RSi9q The communities in Warminster and Yardley are now being operated by Legend Senior Living. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Welltower acquires two Philadelphia-area senior living communities for $42.7M
https://pnbn.org
-
Xiaorong He on Boehringer Ingelheim’s Investments in AI, Broader Applications in Pharma https://lnkd.in/gQEM9JqB In addition to highlighting some of the AI-based partnerships and tools that Boehringer has invested, the conversation also touches on areas where the technology could improve the pharma value chain more broadly. The post Xiaorong [...]
Xiaorong He on Boehringer Ingelheim’s Investments in AI, Broader Applications in Pharma
https://pnbn.org
-
Under-the-skin Keytruda comparable to infused version in Phase 3 study, Merck says https://lnkd.in/gUgAUaKF An experimental under-the-skin injection of Merck & Co.’s cancer immunotherapy Keytruda showed similar characteristics as the current intravenous formulation in a Phase 3 clinical trial, the company said Tuesday. The drugmaker plans to discuss data [...]
Under-the-skin Keytruda comparable to infused version in Phase 3 study, Merck says
https://pnbn.org
-
Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy https://lnkd.in/gWRwy3nW CAMBRIDGE, Mass, Nov. 25, 2024 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the U.S. Food and Drug Administration (FDA) [...]
Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy
https://pnbn.org
-
What to make of Trump’s health care nominees https://lnkd.in/gmEarRxK The presumptive new CDC director, Dave Weldon, is a known vaccine safety skeptic. In contrast, the FDA choice — Johns Hopkins surgeon Marty Makary — has largely been met with… Click here to view original [...]
What to make of Trump’s health care nominees
https://pnbn.org